MX2015001341A - Producto novedoso de leche en polvo y metodo para preparar el mismo. - Google Patents
Producto novedoso de leche en polvo y metodo para preparar el mismo.Info
- Publication number
- MX2015001341A MX2015001341A MX2015001341A MX2015001341A MX2015001341A MX 2015001341 A MX2015001341 A MX 2015001341A MX 2015001341 A MX2015001341 A MX 2015001341A MX 2015001341 A MX2015001341 A MX 2015001341A MX 2015001341 A MX2015001341 A MX 2015001341A
- Authority
- MX
- Mexico
- Prior art keywords
- powdered milk
- milk product
- angiogenin
- product
- producing same
- Prior art date
Links
- 235000008476 powdered milk Nutrition 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 102100022987 Angiogenin Human genes 0.000 abstract 4
- 108010072788 angiogenin Proteins 0.000 abstract 4
- 239000007857 degradation product Substances 0.000 abstract 3
- 239000000047 product Substances 0.000 abstract 3
- 208000010392 Bone Fractures Diseases 0.000 abstract 2
- 208000020084 Bone disease Diseases 0.000 abstract 2
- 102000015833 Cystatin Human genes 0.000 abstract 2
- 208000001132 Osteoporosis Diseases 0.000 abstract 2
- 206010003246 arthritis Diseases 0.000 abstract 2
- 108050004038 cystatin Proteins 0.000 abstract 2
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/146—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
- A23C9/1465—Chromatographic separation of protein or lactose fraction; Adsorption of protein or lactose fraction followed by elution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/27—Endoribonucleases producing 3'-phosphomonoesters (3.1.27)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Medicinal Preparation (AREA)
- Seasonings (AREA)
Abstract
Un objetivo de la invención es proporcionar un producto de leche en polvo seguro y novedoso que sea útil en la prevención y el tratamiento de diversos trastornos óseos tales como osteoporosis, fracturas, reumatismo, y artritis tomándolo diariamente. Un producto de leche en polvo que contiene 1.4 hasta 24 mg/15 mg de angiogenina y/o angiogenina hidrolizada, y cistatina y/o cistatina hidrolizada a una proporción en masa de 0.03 hasta 1.3 con relación a la angiogenina y/o angiogenina hidrolizada. Los huesos se pueden fortalecer, y diversos trastornos óseos tales como osteoporosis, fracturas de huesos, reumatismo, y artritis se pueden evitar o tratar al tomar producto de leche en polvo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2012/069397 WO2014020681A1 (ja) | 2012-07-31 | 2012-07-31 | 粉乳類及びその製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015001341A true MX2015001341A (es) | 2015-09-04 |
MX366535B MX366535B (es) | 2019-07-12 |
Family
ID=50027413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015001341A MX366535B (es) | 2012-07-31 | 2012-07-31 | Producto novedoso de leche en polvo y metodo para preparar el mismo. |
Country Status (14)
Country | Link |
---|---|
US (3) | US20160015790A1 (es) |
EP (1) | EP2880983B1 (es) |
JP (1) | JP6140161B2 (es) |
KR (2) | KR20190095541A (es) |
CN (1) | CN104507321B (es) |
AU (1) | AU2012386764B2 (es) |
BR (1) | BR112015002046A2 (es) |
CA (1) | CA2879995C (es) |
MX (1) | MX366535B (es) |
MY (1) | MY167577A (es) |
PH (1) | PH12015500052B1 (es) |
SG (1) | SG11201500458PA (es) |
TW (1) | TWI626009B (es) |
WO (1) | WO2014020681A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114403235A (zh) * | 2022-01-10 | 2022-04-29 | 成都桥然生物科技有限公司 | 一种用于预防老年骨质疏松的骨善益生菌配方奶粉 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3112637B2 (ja) * | 1994-09-30 | 2000-11-27 | 雪印乳業株式会社 | 骨強化剤 |
JP3929088B2 (ja) * | 1996-06-20 | 2007-06-13 | 雪印乳業株式会社 | 骨形成促進及び骨吸収防止剤 |
US6041007A (en) * | 1998-02-02 | 2000-03-21 | Motorola, Inc. | Device with programmable memory and method of programming |
JP4592127B2 (ja) | 1999-03-30 | 2010-12-01 | 雪印乳業株式会社 | 骨吸収抑制剤 |
JP4647750B2 (ja) * | 2000-06-20 | 2011-03-09 | 雪印乳業株式会社 | 乳塩基性シスタチン高含有画分及びその分解物の製造法 |
EP1602284A1 (en) * | 2000-06-09 | 2005-12-07 | Snow Brand Milk Products, Co., Ltd. | Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof |
US6649590B2 (en) * | 2000-06-09 | 2003-11-18 | Snow Brand Milk Products Co., Ltd. | Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof |
JP4913587B2 (ja) | 2006-12-28 | 2012-04-11 | 雪印メグミルク株式会社 | ペプチドおよびタンパク質定量法 |
AU2008320270B2 (en) * | 2007-11-01 | 2013-06-06 | Megmilk Snow Brand Co., Ltd. | Bone-strengthening food material |
AU2009246053B2 (en) * | 2008-05-14 | 2014-07-24 | Agriculture Victoria Services Pty Ltd. | Use of angiogenin or angiogenin agonists for treating diseases and disorders |
AU2009246052A1 (en) * | 2008-05-14 | 2009-11-19 | Agriculture Victoria Services Pty Ltd | Orally administrable dosage forms comprising angiogenin and uses thereof |
-
2012
- 2012-07-31 CA CA2879995A patent/CA2879995C/en active Active
- 2012-07-31 CN CN201280074987.0A patent/CN104507321B/zh active Active
- 2012-07-31 MY MYPI2015700278A patent/MY167577A/en unknown
- 2012-07-31 KR KR1020197023057A patent/KR20190095541A/ko not_active Ceased
- 2012-07-31 KR KR20157004114A patent/KR20150036677A/ko not_active Ceased
- 2012-07-31 BR BR112015002046A patent/BR112015002046A2/pt not_active Application Discontinuation
- 2012-07-31 WO PCT/JP2012/069397 patent/WO2014020681A1/ja active Application Filing
- 2012-07-31 AU AU2012386764A patent/AU2012386764B2/en active Active
- 2012-07-31 US US14/417,888 patent/US20160015790A1/en not_active Abandoned
- 2012-07-31 SG SG11201500458PA patent/SG11201500458PA/en unknown
- 2012-07-31 EP EP12882312.7A patent/EP2880983B1/en not_active Not-in-force
- 2012-07-31 JP JP2014527854A patent/JP6140161B2/ja active Active
- 2012-07-31 MX MX2015001341A patent/MX366535B/es active IP Right Grant
-
2013
- 2013-07-26 TW TW102126969A patent/TWI626009B/zh active
-
2015
- 2015-01-08 PH PH12015500052A patent/PH12015500052B1/en unknown
-
2017
- 2017-07-21 US US15/656,099 patent/US20170319666A1/en not_active Abandoned
-
2019
- 2019-05-20 US US16/416,770 patent/US20190269763A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2880983B1 (en) | 2017-07-26 |
CA2879995A1 (en) | 2014-02-06 |
EP2880983A4 (en) | 2016-01-13 |
CA2879995C (en) | 2019-09-03 |
EP2880983A1 (en) | 2015-06-10 |
TWI626009B (zh) | 2018-06-11 |
BR112015002046A2 (pt) | 2017-07-04 |
MX366535B (es) | 2019-07-12 |
JP6140161B2 (ja) | 2017-05-31 |
PH12015500052A1 (en) | 2015-03-02 |
US20170319666A1 (en) | 2017-11-09 |
CN104507321A (zh) | 2015-04-08 |
AU2012386764B2 (en) | 2016-05-05 |
JPWO2014020681A1 (ja) | 2016-07-11 |
US20160015790A1 (en) | 2016-01-21 |
CN104507321B (zh) | 2018-01-02 |
NZ704917A (en) | 2016-01-29 |
MY167577A (en) | 2018-09-20 |
PH12015500052B1 (en) | 2019-10-04 |
AU2012386764A1 (en) | 2015-03-05 |
KR20150036677A (ko) | 2015-04-07 |
WO2014020681A1 (ja) | 2014-02-06 |
KR20190095541A (ko) | 2019-08-14 |
TW201408211A (zh) | 2014-03-01 |
HK1207254A1 (en) | 2016-01-29 |
SG11201500458PA (en) | 2015-03-30 |
US20190269763A1 (en) | 2019-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2015189345A3 (en) | Compositions and methods for the diagnosis and treatment of bone fractures and disorders | |
HK1221171A1 (zh) | 用於刺激骨生長的組合物 | |
EP2999747A4 (en) | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants | |
MX2020006237A (es) | Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4. | |
EP4218743A3 (en) | Compositions for use in cartilage breakdown | |
MX356755B (es) | Compuestos de tipo fumagilol y metodos para su elaboración y uso. | |
PH12015500051A1 (en) | Novel fermented milk product and method for producing the same | |
ZA201303529B (en) | Implantable device for preventive or curative treatment of fractures of the femur, associated ancillary device | |
PH12015500049A1 (en) | Novel portein material | |
ZA202000375B (en) | Compounds for the prevention and treatment of medical disorders and uses thereof | |
EP3603657A4 (en) | COMPOSITION CONTAINING AMOMUM VILLOSUM EXTRACT FOR THE PREVENTION, REDUCTION OR TREATMENT OF OBESITY | |
MX2015001344A (es) | Producto novedoso de leche fermentada y metodo para preparar el mismo. | |
IL276786A (en) | Compounds and compositions for the treatment of muscular disorders and bone disorders | |
UA113975C2 (xx) | Застосування фармацевтичної композиції або добавки, яка містить фосфатидилсерин і куркумін (варіанти) | |
MX2015005733A (es) | Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad. | |
PH12015500052B1 (en) | Novel powdered milk product and method for producing the same | |
TW201613569A (en) | Composition consisting of kukoamine A and/or kukoamine B and method of using thereof | |
PH12015500053A1 (en) | Novel cheese and method for producing the same | |
NZ704919A (en) | Powdered milk product, and method for producing same | |
PH12015500048A1 (en) | Novel protein material | |
MY167429A (en) | Novel cheese and method for producing the same | |
PH12015500050A1 (en) | Beverage, and method of producing the same | |
GB2530226A (en) | Chewable tablet | |
MY181546A (en) | Beverage, and method of producing the same | |
MY167427A (en) | Beverage, and method of producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |